http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
MDxHealth Shareholder Transparency Declaration
-
MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar
-
MDxHealth (MDXH) Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test
-
MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test
-
MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisition of GPS Test
-
MDxHealth (MDXH) Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance
-
MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance
-
MDxHealth Provides Business Update
-
MDxHealth Reports Q3-2022 Results
-
MDxHealth Reports Half Year 2022 Results
-
Mdxhealth's New Share Capital Amount and New Number of Shares
-
MDxHealth (MDXH) Acquires Oncotype DX GPS Prostate Cancer Business from Exact Sciences (EXAS)
-
Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results
-
MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings and Resignation of Director
-
MDxHealth (MDXH) Announces Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx for Prostate Cancer
-
Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx for Prostate Cancer
-
MDxHealth Reports Q1-2022 Results
-
MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings
-
MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference
-
MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022
-
MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd
-
MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
MDxHealth Shareholder Transparency Declaration
-
MDxHealth Shareholder Transparency Declarations
-
MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
-
MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States
-
MDxHealth Provides Q3-2021 Business Update
-
MDxHealth Reports Half Year 2021 Results
-
MDxHealth to Present First Half 2021 Financial Results and Corporate Update on August 26
-
MDxHealth Annonce les Résultats de ses Assemblées Générales Annuelle et Extraordinaire des Actionnaires
-
MDxHealth Annonce un Projet Favorable de Couverture par Medicare pour pour le Test SelectMDx pour le Cancer de la Prostate
-
MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings
-
MDxHealth présente son rapport d’activité pour le 1er trimestre de 2021
-
MDxHealth communique ses résultats de l’exercice 2020 et ses perspectives pour 2021
-
MDxHealth Shareholder Transparency Declarations
-
MDxHealth's New Share Capital Amount and New Number of Shares
-
MDxHealth Provides Q3-2020 Business Update
-
MDxHealth announces listing of 20,162,924 existing shares on Euronext Brussels following Equity Investment by MVM Partners
-
MDxHealth Reports Half Year 2020 Results
-
MDxHealth to Report Half Year 2020 Results on Wednesday, August 26, 2020
-
MDxHealth Provides Update on Medicare Coverage for SelectMDx
-
MDxHealth Announces Results of Special and Extraordinary General Shareholders' Meetings
-
MDxHealth (R):
-
MDxHealth Announces its Special and Extraordinary General Shareholders’ Meetings
-
MDxHealth Shareholder Transparency Declarations
-
MDxHealth Announces Results of Annual and Extraordinary General Shareholders' Meetings
-
MDxHealth's New Share Capital Amount and New Number of Shares
-
MDxHealth Shareholder Transparency Declarations
-
MDxHealth Completes the Equity Investment by MVM Partners
-
MDxHealth Announces its Annual and Extraordinary General Shareholders’ Meetings

